Fresh analysis indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who halt traditional diet and exercise plans.
Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.
"Users purchasing these treatments should be informed of the potential of rapid rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
Such speed of regain implies a reversion to original mass in about one and a half years.
Comparing Approaches
The analysis, which examined 37 of studies involving over 9,000 of patients, compared the effects of these new drugs with older methods.
Researchers note that people who shed pounds through diet and exercise usually see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Nutrition scientists propose the mode of action of the jabs explains the accelerated rebound.
These medications imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Long-term administration of the hormone levels far above than normal might result in the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making overeating a significant risk."
A Lifelong Issue?
Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts contend that, due to the high risk of relapse, the treatment is often ongoing.
This opinion is reinforced by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
People who have come off the jabs explain a sudden return of appetite.
"It was like something that goes on and I was suddenly starving," described one woman.
This difficulty is worsened if individuals have not established lasting lifestyle or habit modifications during treatment.
Significant Adoption
Figures suggest that millions of adults in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Use is greater among females than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone cure and maintained weight loss relies on ongoing behavioural changes.